Solventum Corporation (LON:0AD1)

Market Cap	8.80B
Revenue (ttm)	6.59B
Net Income (ttm)	382.61M
Shares Out	n/a
EPS (ttm)	2.20
PE Ratio	23.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72
Average Volume	87
Open	66.25
Previous Close	n/a
Day's Range	66.25 - 66.25
52-Week Range	48.52 - 63.04
Beta	n/a
RSI	n/a
Earnings Date	May 8, 2025

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AD1

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD